JCS Analytics
JCS Analytics
  • Home
  • About
  • Privacy

JCS Analytics - We are analysts. We Ask. We Automate. We Discover.

Details
By J. Smith
J. Smith
Articles
May 26,2024
Hits: 576
  • Type 2 Diabetes
  • Data Analysis
  • Diabetes Management
  • Health Optimization
  • Data-Driven Strategies

Visualizing BGM Data: Tracking Glucose Trends with Fingerstick Readings

Blood Glucose Monitor (BGM) Data

Abstract

Blood glucose monitoring (BGM) through twice daily fingerstick readings has been a fundamental part of tracking and visualizing glucose trends since my type 2 diabetes diagnosis in January 2023. While I now use a continuous glucose monitor (CGM) for continuous tracking, BGM remains an important data source for structured trend analysis, treatment evaluation, and accuracy validation. This project focuses on refining BGM visualizations to align with standardized glucose reporting formats, improving readability and insight into key glucose metrics. The updated approach enhances trend analysis while maintaining the value of fingerstick readings as a reliable reference point.

Key Points

  • BGM remains a valuable tool – Despite using a CGM, twice-daily fingerstick readings provide structured data that support trend analysis and treatment evaluation.
  • Clear trend visualization – Updated BGM visualizations improve formatting consistency, making it easier to track monthly and daily glucose trends.
  • Treatment impact assessment – Data comparisons show significant reductions in average blood glucose and A1c following treatment adjustments.
  • Standardized reporting formats – The visualizations now follow structured layouts similar to CGM reports, improving clarity and usability.
  • BGM as a complementary data source – Fingerstick readings help verify CGM data, track fasting and postprandial glucose, and provide long-term continuity in data analysis.

Read more: Visualizing BGM Data: Tracking Glucose Trends with Fingerstick Readings

Details
By J. Smith
J. Smith
Articles
May 19,2024
Hits: 413
  • Novo Nordisk
  • GLP-1 RA Sales
  • Type 2 Diabetes Management
  • Diabetes Medication Trends
  • Eli Lilly

Exploring the Growth of GLP-1 RA Sales

GLP-1 RA Sales

 

Abstract

The GLP-1 RA market is experiencing rapid growth, fueled by the success of key peptides from Eli Lilly and Novo Nordisk. With new products in development and expanding treatment indications, the market is well positioned for continued advancement. The strategic efforts of these companies, coupled with ongoing innovation and research, are set to drive the future of diabetes management.

Key Points

  • Market Surge: GLP-1 RA sales have experienced exponential growth, reflecting increased demand and acceptance in the diabetes treatment landscape.
  • Key Drivers: Factors driving this growth include improved patient outcomes, expanded indications, and increased awareness of GLP-1 RA benefits.
  • Competitive Landscape: The market is highly competitive, with two pharmaceutical companies investing heavily in GLP-1 RA development and marketing.
  • Economic Impact: The rising sales of GLP-1 RAs have significant economic implications, including increased healthcare spending and impacts on insurance coverage.
  • Future Outlook: Projections indicate continued robust growth for GLP-1 RA sales, driven by ongoing innovations and expanding therapeutic uses.

Read more: Exploring the Growth of GLP-1 RA Sales

Details
By J. Smith
J. Smith
Articles
March 19,2024
Hits: 468
  • AI Innovation
  • Gefion Supercomputer
  • Healthcare Research
  • Quantum Computing
  • Sustainable Technology

Denmark's Leap into AI Innovation: A Model for Future Research and Development

Abstract

Denmark has launched a national AI Innovation Centre, partnering with the Novo Nordisk Foundation, EIFO, and NVIDIA. This initiative aims to leverage Denmark's digital healthcare data to advance drug discovery and precision medicine. Central to this effort is the Gefion supercomputer, equipped with cutting-edge technology for AI research. The project emphasizes sustainability, running on renewable energy, and data sovereignty. Denmark's model showcases the potential of AI to drive innovation and solve global challenges, setting a benchmark for future AI-driven research and development.

Key Points

  • National AI Innovation Centre: Denmark's new initiative to advance AI in healthcare and drug discovery.
  • Partnerships: Collaboration with Novo Nordisk Foundation, EIFO, and NVIDIA.
  • Gefion Supercomputer: A state-of-the-art AI research tool.
  • Focus Areas: Drug discovery, precision medicine, and sustainable practices.
  • Data Sovereignty: Emphasis on secure and ethical data use.
  • Global Impact: Denmark's model aims to inspire worldwide AI-driven research and development.

Read more: Denmark's Leap into AI Innovation: A Model for Future Research and Development

Details
By J. Smith
J. Smith
Articles
March 11,2024
Hits: 439
  • AI Ethics
  • Environmental Impact of AI
  • AI Augmentation
  • Sustainable AI
  • AI Policy and Regulation

Embracing AI: Balancing Augmentation, Ethics, and Environmental Impact

Summary

AI holds tremendous promise for augmenting human work, driving innovation, and enhancing our quality of life. However, realizing this potential responsibly necessitates addressing the ethical, environmental, and social challenges it presents. By pursuing energy-efficient technologies, committing to ethical practices, and engaging in ongoing dialogue about AI's role in society, we can guide the development of AI towards a sustainable and equitable future. As we stand at this crossroads, the choices we make will shape the impact of AI on our world for generations to come. Let's choose a path that amplifies the best of what AI can offer, while vigilantly guarding against its risks.

In the rapidly evolving landscape of artificial intelligence (AI), its burgeoning capabilities have sparked both excitement and concern. AI's potential to augment and enhance work is undeniable, yet the ethical considerations, environmental impact, and potential for misuse loom large. Addressing these concerns is crucial for harnessing AI as a useful and ethically sound tool. This blog post explores how AI can be leveraged to augment human work, the steps needed to mitigate its environmental footprint, and strategies to minimize its use for nefarious purposes.

Key Points

  • AI Augmentation: AI can significantly enhance human work by automating routine tasks, enabling focus on creative and strategic activities, thus increasing productivity and work-life balance.
  • Environmental Impact: AI's substantial energy consumption and e-waste are challenges. Mitigation strategies include improving energy efficiency, transitioning to renewable energy, and implementing regulatory policies.
  • Ethical Considerations: To minimize misuse, AI development must adhere to ethical guidelines, ensure transparency and accountability, and engage the public in discussions about its implications.

Read more: Embracing AI: Balancing Augmentation, Ethics, and Environmental Impact

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8

Page 6 of 8

Recent Activity

November 2025

  • Eli Lilly’s AI Strategy: Opening High-Value Drug Discovery Models to the Biotech Ecosystem

September 2025

  • Bridging Data and Healthcare in the Nordics

August 2025

  • Aligning CGM and BGM Readings Using Python and Tableau
  • Streamlined Drug Shortage Tracking with Python and SQLite

Articles

  • 5K@EASD Race Results: Trends from 2023 and 2024
  • Adapting the 5K@ADA Race Results Project for 2025
  • Advanced Data Retrieval with Python
  • Aligning CGM and BGM Readings Using Python and Tableau
  • Analysis and Visualization of Public Health Agency of Canada COVID Cases
  • Bridging Data and Healthcare in the Nordics
  • Complex Web Scraping with Python
  • Creating a Calculated Field in Tableau to Get Get Data Aggregated by Month in the Correct Order
  • Data Analyst vs. Business Analyst: Similarities and Differences
  • Data Analytics for Type 2 Diabetes
  • Data Science and Responsible AI in the Pharmaceutical Industry: A Case Study of Novo Nordisk
  • Denmark's Leap into AI Innovation: A Model for Future Research and Development
  • Denmark’s Gefion AI Supercomputer Revolutionizes AI-driven Research
  • Eli Lilly’s AI Strategy: Opening High-Value Drug Discovery Models to the Biotech Ecosystem
  • Embracing AI: Balancing Augmentation, Ethics, and Environmental Impact
  • Enhancing Data Analysis and Visualization Workflows with AI
  • Exploring the 2023 5K@EASD Virtual Run: A Tableau Analysis
  • Exploring the Growth of GLP-1 RA Sales
  • How an Hour-by-Hour View Transforms Time in Range Insights
  • How Novo Nordisk is Utilizing AI for Drug Discovery

Top Subjects

  • AI in Drug Discovery
  • Federated Learning
  • Pharmaceutical Data
  • Biotech Innovation
  • Lilly TuneLab
  • NVIDIA
  • Tableau
  • Python
  • Data Visualization
  • Data Analytics
  • Novo Nordisk
  • Tableau Visualizations
  • AI
  • 5K@EASD
  • Data Analysis
  • 5K@ADA
  • Type 2 Diabetes
  • Data Cleaning
  • Drug Discovery
  • AI Innovation
  • Quantum Computing
  • Diabetes Management
  • Race Results
  • Diabetes Awareness
  • Virtual 5K
  • Continuous Glucose Monitor
  • SQLite
  • SQLite Database Management
  • Continuous Glucose Monitoring
  • CGM Data Analysis

Contact Me

Search

End Diabetes Stigma

5K@ADA

5K@EASD

World Diabetes Day

Rochen Web Hosting

Bluesky Social

  • You are here:  
  • Home
  • Articles
 
Copyright © 2025 JCS Analytics. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.